Communicating the Good, Bad & Ugly for CMOs and R&D Leaders in Biotech

This discussion provides helpful approaches for Chief Medical Officers (CMOs) and other R&D leadership in biotech on how to communicate effectively in times of good, bad or unexpected news. Also discussed in this program are factors to evaluate for the discontinuation of a program. Dr Mark Weinberg, Chief Medical Officer and Managing Director of Halloran Consulting Group will be joined by Dr Lee Allen, CMO, Argos Therapeutics to discuss strategic communication strategies CMOs/R&D leadership can utilize to effectively deliver unexpected or difficult news. More specifically: How do you communicate successfully?How does a CMO manage an unexpected realization?Tips on being an advocate and skeptic for your programsFlexibility and decision making with dataScenario planningTips on communicating to the publicEvaluating factors for discontinuing a programRationalizing your portfolio? Who decides? Guests: Lee Allen, MD, PhD, CMO, Argos Therapeutics Mark Weinberg, MD, MBA, CMO and Managing Director, Halloran Consulting Group Producer: Valerie Bowling, Executive Director, PharmaTalk Radio & The Conference Forum Recommended Conference: The CMO and R&D Biotech Leadership Summit, Nov 14-15 in San Francisco. For more info: http://theconferenceforum.org/conferences/rdbiotechleadershipsummit/overview/